The safety and efficacy of laparoscopic para-aortic lymph node biopsy for Cervical Cancer

The safety and efficacy of laparoscopic para-aortic lymph node biopsy for Cervical Cancer - The safety and efficacy of laparoscopic para-aortic lymph node biopsy for Cervical Cancer

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000027458

Enrollment

Registered

2017-05-23

Start date

2017-05-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer

Interventions

Laparoscopic para-aortic lymoh node biopsy

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Cervical Cancer stage 2B-3B (SCC, adenocarcinoma, adenosquamous carcinoma) Patients who have no desire to have more child. Positive pelvic lymph node metastasis by diagnostic imaging.

Exclusion criteria

Exclusion criteria: patient with distal metastasis except para-aortic lymph node metastasis. Patient with severe complication.

Design outcomes

Primary

Measure	Time frame
safety and efficacy	—

Countries

Japan

Contacts

Public ContactKenta Yoshida

Mie University School of Medicine Department of Obstetrics and Gynecology

yoshiken-obgy@clin.medic.mie-u.ac.jp059-232-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026